La Jolla Pharmaceutical Company to Provide GIAPREZA™ (Angiotensin II) for Named Patient Emergency Use in Patients with Septic Shock Due to COVID-19 at University Hospital Frankfurt in Germany


You May Also Like

Retrophin Reports Third Quarter 2016 Financial Results

Positive top-line results from DUET announced in September; additional data to be presented at ...